Related Experiment Video
Updated: Aug 20, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
344
Giant Retroperitoneal Liposarcoma: Correlation Between Size and Risk for Recurrence
Rozan Marjiyeh-Awwad1, Subhi Mansour1, Safi Khuri1,2
1Department of General Surgery, Rambam Health Care Campus, Haifa, Israel.
World Journal of Oncology
|November 21, 2022
Summary
Giant retroperitoneal liposarcomas (RPLs) are rare, often asymptomatic tumors. This review clarifies the relationship between RPL size and recurrence risk, addressing a gap in current medical literature.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Soft tissue sarcomas (STSs) are rare, accounting for ~1% of adult malignancies.
- Liposarcoma is the most common STS subtype, frequently originating in the retroperitoneum (RPL).
- RPLs often grow large asymptomatically, causing late-stage symptoms due to compression of surrounding structures.
Purpose of the Study:
- To review English literature on giant retroperitoneal liposarcomas (RPLs).
- To examine the relationship between RPL tumor size and the risk of recurrence.
Main Methods:
- Literature review of English-language studies on giant RPL.
- Analysis of factors associated with RPL recurrence, focusing on tumor size.
Main Results:
- Giant RPLs are defined as >30 cm or >20 kg, often presenting late due to asymptomatic growth.
- Tumor size is a discussed risk factor for recurrence, though consensus is lacking.
- Histological type, grade, age, and resectability also influence recurrence risk.
Conclusions:
- Clarifying the impact of tumor size on RPL recurrence is crucial for risk stratification.
- Further research is needed to establish definitive size-based risk factors for RPL recurrence.
